Patheon - Drug Development & Manufacturing Services

Adamou Seydou
Gelatin Associate,
Pharma Services,
High Point, NC

Made
With

Heart & Science

Unmatched, Fully Integrated Global Network

Our global network of pharmaceutical development and manufacturing facilities allows Thermo Fisher Scientific the collaboration and reach to ensure your project gets completed quickly and accurately.

Learn More About Our Sites »

Attending DCAT Week in NYC? Let’s Meet.

Meet with our industry leaders at DCAT to learn how Thermo Fisher Pharma Services can support you for every stage of your drug development journey.

Schedule a Meeting »

From Molecule to Medicine. One Partner for Every Step.

Thermo Fisher Scientific’s Patheon and Fisher Clinical Services brands have joined together to create the most complete, end-to-end, truly integrated pharma services offering in the industry. Read more about our combined capabilities and learn how we can take your discovery from clinical to commercial.

Download our Overview Brochure »

Our Capabilities

Small Molecule Development

From route scouting to analytical development & validation, our experts pride themselves on solving your small molecule API development challenges.

Large Molecule Development

We offer comprehensive development and clinical manufacturing services for biologics, ranging from cell line development to cold storage and distribution.

Commercial Manufacturing

We develop or manufacture more than 1,000 large and small molecule products, approved for more than 70 countries. But success isn’t just about scale, it also reflects our ability to deliver exceptional quality and service.

Oral Solid Dose

Every pharmaceutical product presents unique manufacturing challenges, which is why we offer an expansive range of choices in oral solid dosage forms and technologies.

Steriles

We have extensive sterile injectable product development capabilities for liquid-filled and lyophilized vials, including world-class expertise in lyophilization and for pre-filled syringes and cartridges.

Softgel Medication Capsules Manufacturing

Softgels

Softgel technologies are an increasingly popular dosage form in both the prescription (Rx) and OTC markets. Learn more about the many benefits of softgel technology.

Featured Whitepapers & Brochures

Getting to First-in-Human Clinical Trials: A Make-or-Break Milestone for Small Biopharmas

“Faster and better” has become the mantra for biopharmaceutical companies as they face intense pressure to get therapies to market quicker than ever before. The incentive of securing market share with first-to-market offerings is felt by all industry ..

Download

Six API Challenges That Could be Slowing Your Development and How to Avoid Them

The challenges for new drugs looking to enter the market are numerous and varied. But many are self-inflicted – especially in small molecule development. A dangerous perception persists that aside from highly potent APIs, small molecule medications have ..

Download

Infographic: 8 Criteria for a More Successful API Partnership

Outsourcing API development can save time and money. Or it can waste them. Since the difference between these outcomes stems from your choice of a development partner, careful consideration of these eight critical areas is required to help ensure a fast, ..

Download

Events

26/02/2019

6th Annual Biologics Manufacturing Asia 2019 The 6th Annual Biologics Manufacturing Asia 2019 is THE ONLY biomanufacturing focused knowledge-sharing platform in Asia-Pacific that will bring together Asian and International biopharma, biologics contract manufacturing organizations (CMO’s), academic and research institutes, solution providers and technocrats from Singapore, Korea, China, Taiwan, Japan, Australia, and India to convene on the best manufacturing practices in order to have access to faster, cheaper and better biologic drugs.

04/03/2019

The Israel Chapter of PDA: Technology Transfer and Working with CMO-CDMO March 4th, Tel Aviv, Israel – This seminar will provide information on everything from the most important factors to consider when choosing your CMO partner, to learning how to navigate the technology transfer, to building partnership with your contract manufacturer, whether for biologics or for small molecules. Experts from the pharma/biotech industry, as well as… View Article

11/03/2019

BPI West 2019 Whether you are looking to meet potential customers or partners, BPI West is the one-stop shop to network with global scientists and decision makers working across all aspects of the biopharmaceutical field.

News

April 23, 2018

Thermo Fisher Scientific Announces $50 Million Investment to Enhance Biologics Capabilities

March 16, 2018

Thermo Fisher Scientific Announces Plans to Build State-of-the-Art Pharma Services Facility in Rheinfelden (Baden) Germany

October 24, 2017

Tufts Center for Drug Development Study Quantifies Multimillion-Dollar Benefits of Using Single-Source Pharma Drug Development and Manufacturing Model

Patheon Visit us on LinkedIn

November 30

Are you attending Biologics Manufacturing Asia 2019 next week? Don’t forget to stop by booth 5 and connect with our experts about your drug manufacturing needs. http://bit.ly/2GERzIa

April 18

Our work doesn't end when a molecule is sold. Our clients rely on us to help them navigate through clinical phases and commercialization. Learn more about our oral solid dose capabilities: https://bit.ly/2BBMwEh

April 30

Attending the Highly Potent APIs Summit tomorrow in Berlin? Our Executive Director, Global Head of Technical & Scientific Affairs, Anil Kane will be speaking on API trends. Hear a CDMO’s perspective on the future of highly potent drug manufacturing.

PatheonFollow

Patheon@Patheon·

22 Feb

Congratulations to Pacira on completing their first commercial batch at our Swindon site. Dave Stack, CEO of Pacira believes in @thermofisher as a global leader and is looking forward to “advancing this partnership to meet the growing demand.” Learn more: https://t.co/29lyfbNzbm

Reply on Twitter Retweet on Twitter1 Like on Twitter3 Twitter

Patheon@Patheon·

21 Feb

Even after the #molecule changed hands, 52 projects stayed with our team. Find out why our clients rely on us through #clinical phases or commercialization: https://t.co/yWv3g9p9QZ

Reply on Twitter Retweet on Twitter1 Like on Twitter Twitter

Patheon@Patheon·

20 Feb

At the Highly Potent APIs Summit? Don’t miss our Executive Director, Global Head of Technical & Scientific Affairs, Anil Kane offering a #CDMO’s perspective tomorrow.

Reply on Twitter Retweet on Twitter Like on Twitter Twitter

Drug Substance

Drug Product

Small Molecule API Development

Oral Solid Dose

Softgels

Large Molecule Biologics Development

Steriles

Innovative Solutions

Drug Substance

Drug Product

Small Molecule API Commercialization

Oral Solid Dose

Softgels

Large Molecule Biologics Commercialization

Steriles

Innovative Solutions

Unmatched, Fully Integrated Global Network

Attending DCAT Week in NYC? Let’s Meet.

From Molecule to Medicine. One Partner for Every Step.

Our Capabilities

Small Molecule Development

Large Molecule Development

Commercial Manufacturing

Oral Solid Dose

Steriles

Softgels

Meet the People of Patheon

Featured Whitepapers & Brochures

Getting to First-in-Human Clinical Trials: A Make-or-Break Milestone for Small Biopharmas

Six API Challenges That Could be Slowing Your Development and How to Avoid Them

Infographic: 8 Criteria for a More Successful API Partnership

Events

News